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SAMMANFATTNING 
Antikroppar har inte bara förmågan att känna igen och neutralisera hot mot kroppen, utan kan 
också reglera immunresponsen mot sitt specifika antigen. Det är väl känt att Immunoglobulin 
(Ig) G administrerat tillsammans med röda blodkroppar inducerar >99% suppression. Detta 
har använts för att förhindra hemolytisk sjukdom hos nyfödda sedan 60-talet, men man har 
fortfarande inte helt förstått mekanismen bakom fenomenet. IgG-effekten på primärresponsen 
är väl etablerad, men huruvida det också påverkar det immunologiska minnet är fortfarande 
omdebatterat. I den här studien har splenocyter från immuniserade möss överförts till 
individer vars egna immunförsvar slagits ut med hjälp av gammastrålning. Detta genomfördes 
för att bevaka effekten IgG har på det immunologiska minnet utan störningar från 
primärresponsen. Parallellt med detta utfördes även två in situ experiment med olika 
immuniserings-doser. Antikroppsnivåerna i insamlat blodserum bestämdes med ELISA. När 
mössen blev immuniserade med 5x10
6
 röda fårblodkroppar observerades en 10-faldig 
suppression av minnesresponsen i det adoptiva cell överföringsexperimentet. Möss i in situ 
experimentet som immuniserades med den lägre dosen visade full suppression av 
immunologiska minnet medan den grupp möss som immuniserades med den högre dosen 
visade en minnesrespons lika hög som den positiva kontrollgruppen som immuniserats endast 
med de röda fårblodkropparna. Studerar man deras respektive primärrespons ser man att för 
att en komplett suppression av det immunologiska minnet ska kunna ske måste även 
primärresponsen visa total suppression. Detta leder oss till slutsatsen att induceringen av 
minnesresponsen beror på primärresponsen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ABSTRACT 
Apart from recognizing and neutralizing threats, antibodies also have the ability to regulate 
immune responses against their specific antigen. IgG administered together with erythrocytes 
is well known to induce >99% suppression. This has been used to prevent haemolytic disease 
in new-borns since the 1960's, but the mechanism behind it is still not completely understood. 
The effect on the primary response is well established, but its influence on induction of 
immunological memory is still heavily debated. In this study adoptive cell transfer of 
splenocytes to irradiated mice was used to survey the effect IgG has on induction of 
immunological memory without disturbance from the primary IgG response. Alongside this, 
an in situ boost experiment with two different priming doses was performed and antibody 
levels in serum detected using ELISA. When mice were primed with 10µg IgG-anti-SRBC 
(Sheep red blood cells) + 5x10
6
 SRBC, a 10-fold IgG suppression of memory was observed 
when using adoptive transfer and complete suppression of induction of immunological 
memory was seen in in situ boosted mice when primed with a 10 times higher antigen dose. A 
comparison to the primary IgG response in all experiments showed that, to allow for complete 
suppression of memory induction, there must be a complete suppression of the primary 
response as well. This brings us to the conclusion that the induction of the memory response 
depends on the primary response.  
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ABBREVIATIONS 
 
BCR B cell receptor 
ELISA Enzyme-linked immunosorbent assay 
FcγRIIB Fc gamma receptor II B 
IgG Immunoglobulin G 
KLH Keyhole limpet hemocyanine 
OVA Ovalbumin 
PBS Phosphate buffered saline  
RhD Rhesus D antigen 
SRBC  Sheep red blood cells   
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INTRODUCTION 
The adaptive immune system consists of two response types, which involve different parts of 
the immune system and have different functions when eliminating intruders; the cell-mediated 
immunity and the humoral immunity. Cell-mediated immunity defends the body from 
microbial infections that are undetected by circulating antibodies due to their proliferation 
inside host cells such as phagocytes. The destruction of infected cells or the microbe inside 
the phagocyte is mediated by T cells in order to stop the infection from spreading to 
neighbouring tissue. Humoral immunity is composed of antigen specific antibodies circulating 
in the body via blood and secreted mucous. Antibodies recognize, neutralize and destroy 
foreign substances and infections, as well as the microbes causing it, by the activation of 
different effector mechanisms.  
 
Antibody feedback regulation 
Apart from recognizing and eliminating threats, antibodies also have the ability to regulate the 
response against the antigen they bind to, both by endogenous production and passive 
administration. This is known as antibody feedback regulation and can be either completely 
suppressive or enhancing by up to a 1000-fold towards the antigen (Gustavsson et al. 2000). 
Immunoglobulin (Ig) M is known to specifically enhance the humoral immune response 
against the antigen it recognizes (Möller & Wigzell 1965; Henry & Jerne 1968; Wason 1973) 
and IgG can either enhance or suppress the specific response, depending on which antigen it 
is specific against. When administered together with its antigen, IgG specific for soluble 
proteins such as keyhole limpet hemocyanine (KLH) and ovalbumin (OVA) enhance the 
response (Coulie and Van Snick 1985; Heyman 2014) while IgG specific for particulate 
antigens such as erythrocytes effectively suppresses the specific antibody response (Möller & 
Wigzell 1965; Heyman & H Wigzell 1984; Karlsson et al. 1999). 
  
IgG mediated suppression 
The suppressive response mediated by IgG does not only act when administered in a close 
time relation to its antigen; an ongoing antibody response can actually be suppressed by IgG 
given up to 5 days after SRBC (Chan & Sinclair 1973; Henry & Jerne 1968; M. C. I. Karlsson 
et al. 2001). Suppression has been observed with all four subclasses of IgG in mice; IgG1, 
IgG2a, IgG2b and IgG3 (Heyman & Wigzell 1984). The ability of IgG to suppress immune 
responses against erythrocytes has been used clinically to prevent haemolytic disease in new-
born since the 1960's (Clarke et al. 1963). If a rhesus D (RhD) negative woman carrying an 
RhD positive fetus is immunized with fetal erythrocytes through trans placental 
haemorrhaging or during delivery, her immune system will start producing antibodies against 
RhD, leading to the degradation of the fetus red blood cells during the next pregnancy. 
Human IgG anti-RhD antibodies administered passively to the mother usually within 72 hours 
of birth will suppress this response and inhibit haemolytic disease during the next pregnancy. 
Even though this method of medical aid has been used for decades, it is still not clear how this 
suppressive mechanism works.  
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Mechanism behind IgG mediated suppression 
Currently there are three leading hypotheses to explain the suppressive mechanism, the first 
being co-cross linking of inhibitory FcγRIIB and B cell receptor (BCR) by IgG immune 
complexes leading to inhibition of B cell activation. This has been shown to take place in 
vitro (Amigorena et al. 1992; Muta et al. 1994) and is speculated to take place in vivo in a 
similar manner, where the antigen-specific B cells are negatively regulated by the cross 
linking of these receptors by IgG-antigen complexes. However, both F(ab')2 fragments (Tao & 
Uhr 1966; Karlsson et al. 1999) and IgE anti-SRBC (Karlsson et al. 1999), neither of which 
can bind to any FcγR, have shown effective suppression. In other experiments where FcγRIIB 
deficient mice were administered with IgG the response against erythrocytes were suppressed 
as effectively as in wild-type mice, suggesting that suppression does not depend on FcγRIIB 
(Karlsson et al. 1999; 2001). The second explanation is that IgG-antigen complexes are 
disposed by phagocytosis and therefore unable to interact with the immune system. However, 
since FcγR deficient mice also showed suppressed response when given antigen specific IgG, 
any elimination must be independent from these receptors (Karlsson et al. 1999). The third 
and currently most likely hypothesis is the one of epitope masking. The activation of B cells 
would simply be prevented due to the antigen being disguised from B cell recognition when 
bound to IgG antibodies. This fits very well with the majority of experimental data such as the 
independence of FcγRs and that IgE and F(ab')2 have the ability to suppress. This is however 
very hard to show experimentally and waits to be directly proven.  
  
The effect on the primary antibody response when IgG is passively administered is well 
documented (Heyman 2014), but there are different results have been reported when it comes 
to whether it also affects the induction of immunological memory. Some studies show that 
when primed with IgG and antigen together, the induction of memory is suppressed in the 
same manner as the primary immune response (Nicholas & Sinclair 1969; Dresser 1990) or 
suppressed but not to the same extent as the primary response (Heyman & Wigzell 1985) 
while others show that it has no effect on memory responses at all (Safford & Tokuda 1971; 
Brinc et al. 2008).  
 
Scope of this investigation 
Because of these incoherent reports we decided to perform our own experiment on the subject 
in order to determine the level of memory suppression. One way to test the impact on 
immunological memory, while eliminating the risk of endogenous suppression by IgG anti-
SRBC produced during the primary response, is by adoptive cell transfer. With this process 
the recipient group acquires the immunity against the antigen the donating group has received 
without ever having been exposed to it.  
We performed an adoptive cell transfer experiment alongside two in situ boost experiments 
with different boost doses, with the aim to investigate impact on immunological memory in an 
undisturbed environment.  
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MATERIALS AND METHODS 
 
Mice 
BALB/c mice were purchased from Bommice (Ry, Denmark) and kept at the National 
Veterinary Institute, Uppsala, in animal facilities. The Uppsala Animal Research Ethics 
Committee approved all animal experiments performed to gather material for this study.  
 
Antibodies 
Polyclonal IgGb anti-SRBC was prepared from serum collected from CB17 or C57BL/6 mice 
and purified using Protein-A sepharose columns (Amersham Pharmacia Biotech, Uppsala, 
Sweden) followed by dialysis against PBS, sterile filtration and storage at -20°C until use.  
 
Antigens 
SRBC (Håtunalab AB, Håtunaholm, Sweden) stored in Alsever’s solution at 4°C were 
washed in PBS three times before use.  
 
Primary immunization and blood sampling 
Polyclonal IgG anti-SRBC and SRBC in 200 µl PBS was injected into the mice lateral tail 
veins. SRBC was injected 30 minutes past the IgG anti-SRBC immunization. Positive 
controls received SRBC alone and naïve mice were used as negative controls. The ventral tail 
artery was used to collect blood samples. Immunization doses are specified in the figure 
legends.  
 
Boost immunization after adoptive cell transfer or in situ 
Irradiation treatment (7 Gy) was performed on the recipient naïve mice which were then 
rested for 24 h before adoptive cell transfer and antigen boost. Six months after the antibody 
and antigen priming the spleens from all three groups of mice were collected. Single cell 
suspensions were prepared by smashing the spleens through a nylon cloth. The cell 
suspension were washed in Hank´s balanced salt solution (HBSS) and fifteen million 
nucleated spleen cells in 200 µl HBSS were injected in one of the lateral tail veins prior to an 
injection of 5x10
5
 SRBC in 200 µl PBS. In the in situ experiments the mice received boost 
immunizations in the same manner, but no adoptive transfer were performed.  
 
ELISA 
Coating of plates 
Fifty µl of 0.25 µg/ml poly-L-lysine (P1274 Sigma, St. Louis, Missouri, United States) in 
distilled H2O were added to microtiter plates (Costar) and incubated for 45 minutes in 37°C. 
Plates were then washed 3 times in PBS, 100 µl of 0.25% SRBC in PBS was added, and 
plates were incubated at room temperature for 1 hour. Gentle submersion of the plates into 
0.25% glutaraldehyde (Sigma) in PBS for 10 minutes was used to fix the erythrocytes and 
loose cells were removed by washing in PBS two times. Plates were blocked by the addition 
of 150 µl of a PBS solution containing 50 mg/ml dry milk and 0.02% NaN3 and plates kept at 
4°C until used. 
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Assay 
Blocked plates were washed two times in PBS and 50 µl of sample diluted in dilution buffer 
(PBS + 0.05% Tween-20; WVR, Pennsylvania, United States; 0.25% dry milk and 0.02% 
NaN3) to 1:25 and stepwise times two until 1:819,200 (SRBC) and 1:5 in the same manner 
until 1:163,840 (IgG + SRBC and naïve). Plates were then incubated over night at 4°C and 
washed 3 times in PBS + 0.05% Tween. Fifty µl of sheep anti-mouse IgG conjugated with 
alkaline phosphatase (Jackson ImmunoResearch Laboratories, Sacramento, California, United 
States) diluted 1:1000 in dilution buffer were added and incubated in room temperature in 
humid chamber for 3 hours. This was followed by washing 3 times in PBS + 0.05% Tween 
and 2 times in PBS, and the addition of 100 µl of a substrate solution containing 1 
phosphatase substrate tablet (Sigma) per 5 ml substrate buffer (44.4 M dH2O, 1.012 M 
diethanolamine, 0.001 M MgCl2x6 H2O, titrated with 5 M HCl to pH 9.8). After 30 minutes 
of incubation in the dark, OD was measured at 405 nm and the data analyzed with SoftMax 
software (Molecular Devices, Toronto, Canada).  
 
The baseline was established by taking the average of the normal serum OD405nm plus two 
times the standard deviation. Titers were determined as the dilution prior to the first dilution 
with an OD405nm below the baseline.  
 
Statistical analysis 
A two-tailed, non-parametric Mann-Whitney t-test was used in order to determine the 
statistical difference between groups, with the statistical significance levels set as following: 
ns, p > 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001. In cases where only two measuring 
points were available, a third with a value of 1 was added so the test could be performed.   
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RESULTS 
In situ memory response 
Two in situ experiment were performed on BALB/c mice, where one set of mice were primed 
with 10 µg IgG + 5x10
6
 SRBC or 5x10
6
 SRBC alone and one set of mice primed with 50 µg 
IgG + 5x10
7
 SRBC or 5x10
7
 SRBC alone 6 months prior to a 5x10
5
 SRBC boost. ELISA 
screening for IgG anti-SRBC detected present levels in blood serum, collected during three 
separate time points between day 21-49 after boost. When receiving the lower priming 
dosage, only the SRBC group showed induction of memory response (figure 1A). In the mice 
receiving IgG + SRBC, the levels of serum IgG anti-SRBC were as low as the group of mice 
receiving booster alone indicating an almost complete suppression. However, with a higher 
priming dose, the IgG + SRBC group showed no sign of suppression, with an IgG anti-SRBC 
level equally high as the SRBC alone group (figure 1B).  
 
Adoptive transfer memory response 
In parallel to this, an adoptive transfer method was used to avoid suppression of recall 
responses caused by IgG anti-SRBC from the primary response. Donor mice were primed 
with 10 µg IgG + 5x10
6
 SRBC or 5x10
6 
SRBC alone 6 months prior to spleen harvest and 
adoptive transfer. A single cell suspension containing 15x10
6
 nucleated splenocytes was 
transferred into irradiated recipient mice, in combination with a boost of 5x10
5
 SRBC. Blood 
serum was collected during 6 time points from 7 days prior boost until 121 days post boost, 
and IgG anti-SRBC levels were determined by ELISA. The adoptive transfer mice showed 
memory response in both the IgG + SRBC and SRBC groups (figure 1C). However, the 
response in IgG + SRBC was suppressed by a tenfold compared to the SRBC group.  
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Figure 1. IgG impact on immunological memory. A) BALB/c mice primed with 10 µg IgG anti-
SRBC + 5x10
6
 SRBC or 5x10
6
 SRBC alone, and a naïve group were boosted with 5x10
5
 SRBC 6 
months after priming.  B) BALB/c mice immunized with 50 µg IgG anti-SRBC + 5x10
7
 SRBC or 
5x10
7
 SRBC 6 months prior to boost of 5x10
5
 SRBC. C) BALB/c mice were primed with 10 µg IgG 
anti-SRBC + 5x10
6
 SRBC or 5x10
6
 SRBC alone 6 months prior to spleen removal. A negative control 
group of naïve mice were used as well. A single cell suspension (containing 15x10
6
 nucleated 
splenocytes) made from the removed spleens were then injected intravenously together with a 5x10
5
 
SRBC boost into naïve mice 24 hours after irradiation treatment (7 Gy). IgG anti-SRBC levels were 
determined in all experiments by ELISA using blood serum collected at indicated time points. SRBC 
immunized group was analysed with a serum dilution of 1:25 and then stepwise by two until 
1:819,200, IgG + SRBC and naïve groups with a dilution of 1:5 to 1:163,840. Titers were determined 
as the dilution prior to the first dilution with an OD405nm below the baseline and are presented as 
log10 on the y-axis. In experiment A, n = 5-7/group and in experiment B, n = 2-6/group. A Mann-
Whitney U-test was used to detect statistical differences between IgG + SRBC and SRBC groups 
(without parentheses) and IgG + SRBC and naïve groups (with parentheses): ns, p > 0.05; *, p < 0.05; 
**, p < 0.01; ***, p < 0.001.   
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DISCUSSION 
Several studies have been made on the impact of IgG on immunological memory, but the 
effect of endogenous IgG generated from the primary response had never been excluded. In 
this study we wanted to record the level of suppression of memory in an undisturbed 
environment and therefore adoptive transfer was used.  
 
When measuring the IgG response to antigen in blood it can be problematic to distinguish the 
antibodies administered from the ones produced in vivo. One way to work around this is by 
administering antibodies of another allotype than the one produced by the animals own 
immune response. Using an ELISA method that discriminates between allotypes allows an 
accurate detection of the antibody response to the immunization rather than to the antibodies 
administered. In this case however, we waited for 6 months before boost, in order for the 
endogenous IgG anti-SRBC levels in the bloodstream to go down.  
 
Interestingly, the in situ experiment where the mice received the higher priming dose showed 
no suppression on memory in contrast to the complete suppression seen in connection to the 
lower dose. If we look at the primary IgG anti-SRBC response (Bergström et al. Unpublished 
data) in these two experiments, we see that the mice receiving the lower priming dose have a 
primary response that is completely suppressed, whereas the ones receiving the higher 
priming dose show a response around day 21. In the IgG + SRBC group in the higher priming 
dose experiment there were two extreme outliers; one with a really high response and one 
barely responding at all. This obviously affects the main outcome, and the experiment would 
have to be repeated to establish more reliable results.  
 
In the adoptive transfer experiment, the IgG + SRBC group showed a suppressed memory 
response by around a 10-fold compared to the levels of the SRBC group. The primary IgG 
response in this experiment showed an initial suppression which turned into an increasing 
response around day 21. Something seen in all of these experiments is that in order to allow 
for complete suppression of the induction of memory response, the primary response must be 
completely suppressed as well. This brings us to the conclusion that the memory response 
depends on the primary response.  
 
So how come the primary response differs between the experimental groups? The difference 
on suppression in the in situ groups could be due to the differing priming doses administered. 
Levels of suppression have been shown to correlate with the amount of administered IgG, 
where a higher dose equals a higher suppressive response. (Henry & Jerne 1968; Heyman & 
Wigzell 1984) However, in these previous experiments varying doses of IgG were 
administered together with a constant dose of SRBC. Our experiment provides data on the 
suppression after the administration of an increased dose of both SRBC and IgG which could 
bring new insights into the suppressive impact depending on proportions between antibody 
and antigen. In our higher dose experiment, only a 5 times higher dose of IgG anti-SRBC was 
administered together with a 10 times higher dose of SRBC, suggesting that the amount of 
administered antibody was not enough to effectively induce a complete suppression.  
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One explanation for the incoherence in the previous results regarding IgG impact on 
immunological memory may be that most studies only measured the primary IgM response, 
assuming that a complete suppression of primary IgM meant the same on primary IgG. 
However IgM responses are much more easily suppressed than IgG responses, as shown in 
these experiments and by Bergström et al. (unpublished data) where a complete suppression 
of primary IgM responses not necessarily meant a complete suppression of the IgG response. 
In the studies where primary IgG were detected, samples were taken within a close time frame 
after the immunization. However, in this study we see an IgG response around three weeks 
after immunization, so samples collected before this might show a complete suppression even 
though it may only be initial.  
 
In conclusion, this study showed that the extent of memory suppression is dependent on the 
primary response, although further investigations should be performed in order to confirm 
these findings. A greater understanding of how memory suppression operates may lead to 
advantages within clinical IgG treatment to prevent haemolytic disease in new-born. 
Currently the polyclonal antibodies specific against RhD are prepared from large amounts of 
human sera. Given enough insight into the mechanism, monoclonal IgG anti-RhD antibodies 
could be produced and the risks of infection decreased.   
10 
 
ACKNOWLEDGEMENTS 
Many thanks to my assistant supervisors Joakim Bergström and Hui Xu, for teaching me how 
to perform an ELISA to perfection, for answering my sometimes stupid questions, and for 
their patient and constructive scrutiny on the very many drafts of this report. I also send my 
endless appreciation to my main supervisor Sara Wernersson, for making sure everything was 
done according to SLU's guidelines and helping me with all the administrative parts. And of 
course, thank you to my examiner, Gunnar Pejler, for putting your time and effort into 
evaluating my performance during this project. And last but not least, I'd like to thank Birgitta 
Heyman: for all of her published articles allowing me to grasp the essence of this project, and 
for letting me do it in her group.   
11 
 
REFERENCES 
Amigorena, S. et al., 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors 
in B lymphocytes. Science (New York, N.Y.), 256(5065), pp.1808–12.  
Brinc, D. et al., 2008. Immunoglobulin G-mediated regulation of the murine immune response to 
transfused red blood cells occurs in the absence of active immune suppression: implications 
for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and 
newborn? Immunology, 124(1), pp.141–6.  
Chan, P.L. & Sinclair, N.R., 1973. Regulation of the immune response. VI. Inability of F(ab’) 2 
antibody to terminate established immune responses and its ability to interfere with IgG 
antibody-mediated immunosuppression. Immunology, 24(2), pp.289–301.  
Clarke, C. a. et al., 1963. Further Experimental Studies on the Prevention of Rh Haemolytic 
Disease. British Medical Journal, 1, pp.979–984. 
Coulie, G., Van Snick, J., 1985. Enhancement of IgG anti-carrier responses by IgG2 anti-hapten 
antibodies in mice. European Journal of Immunology. 15(8) pp.793-798. 
Dresser, D.W., 1990. Feedback by early and late primary antisera on the primary and secondary 
adoptive immune responses of mice to burro erythrocytes. Cellular Immunology, 127(2), 
pp.405–19. 
Henry, C. & Jerne, N.K., 1968. Competition of 19S and 7S antigen receptors in the regulation of 
the primary immune response. The Journal of Experimental Medicine, 128(1), pp.133–52. 
Heyman, B., 2014. Antibodies as Natural Adjuvants. Current Topics in Microbiology and 
Immunology, 382, pp.201–219.  
Heyman, B. & Wigzell, H., 1984. Immunoregulation by monoclonal sheep erythrocyte-specific 
IgG antibodies: suppression is correlated to level of antigen binding and not to isotype. 
Journal of Immunology, 132(3), pp.1136–1143. 
Heyman, B. & Wigzell, H., 1985. Specific IgM enhances and IgG inhibits the induction of 
immunological memory in mice. Scandinavian Journal of Immunology, 21, pp.255–266. 
Karlsson, M. et al., 1999. Efficient IgG-mediated suppression of primary antibody responses in 
Fcgamma receptor-deficient mice. Proceedings of the National Academy of Sciences of the 
United States of America, 96(5), pp.2244–2249. 
Karlsson, M.C.I., Getahun, A. & Heyman, B., 2001. FcγRIIB in IgG-Mediated Suppression of 
Antibody Responses: Different Impact In Vivo and In Vitro 1. Journal of Immunology, 
167(20), pp.5558–5564. 
Muta, T. et al., 1994. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB 
modulates B-cell receptor signalling. Nature, 369(6478), p.340.  
Möller, G. & Wigzell, H., 1965. Antibody-induced suppression of 19S and 7S antibody response. 
The Journal of Experimental Medicine, 121(8), pp.969–989. 
12 
 
Nicholas, R. & Sinclair, S.C., 1969. Regulation of the immune response. I. Reduction in ability of 
specific antibody to inhibit long-lasting IgG immunological priming after removal of the Fc 
fragment. The Journal of Experimental Medicine, 129(6), pp.1183–201.  
Safford, J. & Tokuda, S., 1971. Antibody-mediated suppression of the immune response: effect on 
the development of immunologic memory. The Journal of Immunology, 107(5), pp.1213–
1225.  
Wason, W.M., 1973. Regulation of the immune response with antigen specific IgM antibody: a 
dual role. The Journal of Immunology, 110(5), pp.1245–1252. 
 
 
 
 
 
 
 
 
 
